Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Source link
You May Also Like
Posted in
Markets
Nio’s stock dives as EV maker raises $1 billion at shareholders’ expense
Posted by
Admin
More From Author
Links 8/7/2025 | naked capitalism
